BDX vs WST — Key Metrics
| Metric | BDX (BECTON DICKINSON & CO) | WST (WEST PHARMACEUTICAL SERVICES INC) |
|---|---|---|
| Price | 216.08 | 404.02 |
| Market Cap | 58.86 Billion | 28.14 Billion |
| P/E (TTM) | 65.08 | 45.04 |
| P/B (Quarterly) | 1.975 | 9.779 |
| P/S (TTM) | 2.82 | 8.29 |
| Net Profit Margin (TTM) | 4.5 | 18.8 |
| Gross Margin (TTM) | 46.4 | 37.6 |
| ROE (TTM) | 3.8 | 21.1 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Greatly Underperform
Recommendation Summary
BDX is not scored by the AI model, which covers non-financial S&P 500 companies (banks, insurers and asset managers report on a different basis), so there is no recommendation for this pair.
Financial Metrics
| BDX | Metrics | WST |
|---|---|---|
| $216.08 | Price | $404.02 |
| — | Market Capitalization | — |
| 65.08 | Price to Earnings Ratio | 45.04 |
| 2.82 | Price to Sales | 8.29 |
| 23.25 | Price to FCF Ratio | 48.5 |
| 6.08 | Price to Gross Profit | 22.04 |
| 51.86 | Price to R&D | 372.28 |
| 7.23 | Price to Current Assets | 15.49 |
BDX vs WST at a glance
Becton Dickinson & CO (BDX) and West Pharmaceutical Services INC (WST) are both Medical Instruments & Supplies companies in the Healthcare sector. BDX is the larger, at $58.9 billion in market value against $28.1 billion for WST, about 2.1 times the size.
On trailing-twelve-month figures, BDX trades at 65.1 times trailing earnings and WST at 45.0; net profit margins are 4.5% and 18.8%.